- Bupa Platinum consultant
-
Fee assured
-
Awaiting
verification
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
James Good is a leading Birmingham-based cancer specialist. After training in Cambridge and London, he has established a cutting edge practice focused on gastro-intestinal and head/neck cancer. James works closely with top surgeons and key medical specialties to develop an integrated treatment plan that achieves the best possible outcomes, whilst ensuring that wellbeing is made a key priority. James' patients tell him that they value his warm, pragmatic and open approach.
James believes that everyone with cancer should have access to innovative and evidence-based treatment. He is a national expert in the treatment of liver and pancreatic tumours with advanced radiotherapy and has delivered a number of clinical trials investigating immunotherapy and novel drug/radiotherapy combinations.
Since 2018, James has been Clinical Director of Stereotactic Radiotherapy for GenesisCare, the UK's largest provider of private radiotherapy. He has lead the implementation of MRI-guided radiotherapy in Oxford and London - a technique that offers a step-change in accurate tumour targeting.
Areas of interest
Bowel cancer; Cholangiocarcinoma; Colon cancer; Liver cancer; Liver metastases; Oral cancer; Pancreatic cancer; Rectal cancer; Salivary gland cancer; Sinus cancer; Throat cancer; Thyroid cancer; Tongue cancer; Tonsil cancer; Chemotherapy; CyberKnife; Immunotherapy; Personalised medicine; Radiotherapy; SABR; SBRT; SIRT; MRIdian
Medical secretaries
- Sheena Collins
- Cancer Centre Queen Elizabeth Hospital Edgbaston BIRMINGHAM B15 2TH
- 0121 371 3599
- 0121 371 3602
- sheena.collins@uhb.nhs.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
A1080
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
Priory Hospital (The) (5-50) Spire Little Aston Hospital (5-50)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)
Spire Little Aston Hospital (5-50)
-
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (5-50)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Spire Little Aston Hospital (5-50)
-
X6950
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (5-50)
-
X0001
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 0-7 days - (5-50)
GenesisCare, Birmingham (5-50)
-
X6772
Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)
GenesisCare, Birmingham (1-5)
-
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)
GenesisCare, Birmingham (1-5)
-
X0008
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)
GenesisCare, Birmingham (1-5)